© 2001 American Heart Association, Inc.
Review |
Functional Consequences of Integrin Gene Mutations in Mice
* From the Department of Experimental Pathology, Lund University, Lund, Sweden.
Correspondence to Daniel Bouvard or Cord Brakebusch, Lund University Hospital, Department of Experimental Pathology, 22185 Lund, Sweden. E-mail Daniel.Bouvard{at}pat.lu.se or Cord.Brakebusch@pat.lu.se
 |
Abstract |
|---|
 Top Abstract IntroductionEarly Mouse DevelopmentReferences |
|---|
Abstract— Integrins are cell-surface receptors responsible for cell attachment to extracellular matrices and to other cells. The application of mouse genetics has significantly increased our understanding of integrin function in vivo. In this review, we summarize the phenotypes of mice carrying mutant integrin genes and compare them with phenotypes of mice lacking the integrin ligands.
Key Words: integrin • knockout • extracellular matrix
|
Introduction |
|---|
|
TopAbstractIntroductionEarly Mouse DevelopmentReferences |
|---|
Cell-cell and cell-matrix interactions play essential roles in development, tissue function, and repair. During morphogenesis and tissue homeostasis, specific signals emerge from the environment, cross the cell membrane, and control many aspects of cell behavior, including migration, proliferation, survival, and differentiation. Integrins are cell adhesion molecules that can transmit such signals. They are heterodimeric transmembrane glycoproteins, composed of noncovalently-associated
and ß subunits. To date, 24 integrin receptors assembled from various combinations of 18 and 8 ß chains have been described (Figure 1). The extracellular domain of integrins binds the cognate ligand, whereas the cytoplasmic domain is linked to the actin cytoskeleton. Integrins can bind extracellular matrix (ECM) proteins, such as collagens, fibronectins, and laminins, and cellular receptors, such as vascular cell adhesion molecule-1 (VCAM-1) and the intercellular cell adhesion molecule (ICAM) family.1 Certain integrins share the same extracellular ligand, but on the other hand, several ligands are recognized by the same integrin. Ligand binding is followed by recruitment of several signaling proteins to the integrin and initiation of a signaling cascade that modulates cell behavior and gene transcription.2,3
|
During the last two decades, most of the information about integrin function has been derived from in vitro cell culture systems. Gene targeting technology recently made it possible to generate mice that lack specific integrins in a constitutive or cell type–specific manner. Analyses of these mice demonstrate how integrin-mediated adhesion and signal transduction affect development and maintenance of tissues and provide additional insight into integrin function in various diseases. In this review, we summarize the phenotypes of mice carrying mutant integrin genes and compare them with the relevant genetic models bearing mutations in some integrin ligands (Table).
|
|
Early Mouse Development |
|---|
|
TopAbstractIntroductionEarly Mouse DevelopmentReferences |
|---|
Ablation of integrin genes leads to various phenotypes during mouse development, ranging from apparently normal mice to early lethality (Figure 2). For example, disruption of the ubiquitously expressed ß1 integrin gene leads to the loss of at least 12 different integrin receptors and results in peri-implantation lethality characterized by an inner cell mass (ICM) failure.4,5 Fertilization of ß1-null oocytes and the entire preimplantation development is normal. This is most likely because of the presence of maternal ß1 integrin mRNA and protein.6 A possible explanation of the ICM failure could be the loss of ß1-mediated survival signals. At peri-implantation stage, the ICM cells facing the blastocyst cavity differentiate into primitive endodermal cells and lay down a basal membrane (BM). This leads to polarization of adjacent ICM cells and their differentiation into ectodermal cells. The inability of the ectodermal cells to interact with BM components through integrins could lead to their loss by apoptosis and arrest of additional development.7 Another possibility could be that the lack of ß1 integrins leads to abnormal BM assembly. ß1 integrin is crucial for normal expression and correct assembly of BM components into a supramolecular structure.8–12 The complete absence of a BM is observed in mice carrying a null mutation in the laminin
1 chain gene.13 Laminins are heterotrimeric glycoproteins composed of , ß, and subunits. Laminin 1-null mice fail to develop a BM between primitive endoderm and ICM, and, like the ß1-null mice, they die at the peri-implantation stage.13 A recent study demonstrated the role of the BM in regulating apoptosis and cavity formation using embryoid bodies derived from laminin 1-null embryonic stem (ES) cells.14 In laminin 1-null embryoid bodies, the ectoderm never polarizes and the inner cells never apoptose to form cavities. An identical phenotype is observed in ß1-null embryoid bodies (R. Fässler, unpublished data, 1995).
|
Deletion of the integrin 5 gene leads to an embryonic lethality around embryonic day 9.5 (E9.5) and E10 with variable degrees of embryonic and extra-embryonic defects that partly depend on the genetic background.15,16 5ß1 plays a role in neural crest survival and maintenance of mesoderm derivatives after the gastrulation stage but is dispensable for initial commitment of mesodermic cells.17 Knockout of the 5ß1 ligand fibronectin (FN) results in a more severe phenotype, suggesting that other FN-binding integrins compensate in the 5-null mouse. Fibronectin-null embryos implant and initiate gastrulation normally. Shortly thereafter, they show defects in neural tube closure, in the cardiovascular system, and in somite formation and die at E8.5.18
4-Null embryos fail to fuse the allantois with the chorion during placentation, show defects in the heart and vasculature, and display abnormalities in the cranial and facial structure.19 4-Null embryos die at two different stages during development. The first wave is around E9.5 to E11.5 and is caused by the failure of allantois-chorion fusion, and the second is between E11.5 and E14 and is caused by massive heart hemorrhage. 4ß1 Integrin can bind fibronectin and VCAM-1. The mutant phenotype is mainly attributable to a defect in VCAM-1 binding, because mice lacking VCAM-1 also fail to fuse the allantois with the chorion and have cardiac defect similar to 4-null mice.20,21
v Integrins can associate with ß1, ß3, ß5, ß6, and ß8 subunits. They bind to both fibronectin and vitronectin, except for vß6 integrin, which binds to fibronectin, vitronectin, and tenascin-C, and vß8, which binds only to fibronectin.1 Several reports have shown that vß3 and vß5 integrins are crucial for tumor angiogenesis.22 Therefore, it came by surprise that v-null mice, which lack both of these receptors, have no defects in vasculogenesis and angiogenesis. Approximately 80% of the v-null mice die between E10 and E12 because of a placenta defect characterized by a poorly developed labyrinthine zone and reduced interdigitation of fetal and maternal vessels. The remaining 20% die at birth from massive hemorrhages and cleft palates.23 Because vitronectin, tenascin-C, and osteopontin-null mice have no obvious phenotype during the early mouse development,24 the v-null phenotype is most likely attributable to a lack of fibronectin binding.
A recent study investigated 5-/-v-/- double knockouts, which lack several major fibronectin receptors. The mutants die between E7.5 and E8 and display a severe gastrulation defect, with a lack of anterior mesoderm.16 It is noteworthy that this phenotype is even more severe than that observed in the fibronectin-null mutants, suggesting the presence of additional ligands for these two receptors at this developmental stage.
Hematopoiesis
Hematopoietic stem cells (HSCs) and endothelial cells are derived from a common precursor cell called hemangioblast. HSCs are generated outside the embryo proper, in the yolk sac (YS), and within the embryo in the para-aortic splanchnopleura/aorta-gonad mesonephros region. At around E8.5, when circulation starts in mouse, the HSCs are present in the fetal blood, and at E10 they start to colonize the fetal liver. Later, hematopoietic progenitors seed the thymus, spleen, other lymphoid organs, and bone marrow. In the adult mouse, HSCs reside in the bone marrow, but differentiated leukocytes circulate through the body and extravasate into infected tissues. Because of the early embryonic lethality of integrin ß1-null mice, chimeric mice have been used to analyze ß1 function in the hematopoietic system. These mice revealed that ß1 integrin is not required for the generation of progenitor cells in the para-aortic splanchnopleura/aorta-gonad mesonephros region and the YS but is essential for them to colonize the fetal liver.25,26 Differentiation of ß1-null precursor cells in the presence of cytokines in vitro and in reaggregated fetal organ cultures of liver and thymus is normal, indicating that ß1 integrins are crucial for the migration of HSCs into, but not for their development within, hematopoietic organs. Also, the homing of adult HSCs to the bone marrow is critically dependent on ß1 integrin expression. Accumulation of transferred ß1-null precursor cells in the blood in vivo and reduced adhesion of other cells to endothelioma cells in vitro suggests that ß1 integrin is essential for the adhesion of HSC to the vessel wall.26 Whether it plays an additional role at later processes (transmigration though the endothelium or extravascular migration) is not clear. Mouse HSCs express 4ß1, 5ß1, and 6ß1 integrin. Because individual knockouts of these subunits do not interfere with HSC homing,27–29 either a combination of these receptors or another integrin of ß1 family mediates HSC migration to the bone marrow.
Deletion of the ß7 integrin subunit, which can associate with 4 and E, results in defective migration of T cells to Peyer’s patches and a reduced number of lamina propria and intraepithelial lymphocytes.30 Migration of lymphocytes to the Peyer’s patches is mediated by 4ß7 binding to the endothelial MadCAM-1 receptors on the high endothelial venules in the gut. This was confirmed with mice lacking MadCAM-1 because of ablation of the transcription factor NKX2.3 gene, which controls MadCAM-1 expression. These mice have very small Peyer’s patches only visible after microscopic inspection.31 Targeted disruption of the E gene leads to a reduction of T cells in lamina propria and gut epithelium but not in Peyer’s patches.32 Mice lacking both ß7 integrin and L-selectin suffer from a nearly complete impairment of lymphocyte migration to mesenterial lymph nodes.33
Because of the early embryonic lethality of 4-null mice, the function of 4 integrin in the hematopoietic system was studied in 4-null chimeric mice. The 4 subunit can associate with ß1 and ß7 integrin and is important for the differentiation of erythroid, myeloid, and B cell progenitors during embryogenesis.34 Because in vitro differentiation in colony assays is normal, the defects observed in vivo are quite likely attributable to impaired interaction of the 4-null progenitors with the microenvironment in the hematopoietic organs. Furthermore, no 4-null erythrocytes, almost no B lymphoid cells, and only a few myeloid cells are present in adult chimeric mice, indicating an important role of 4 integrins in the postnatal hematopoietic development.34 The underlying mechanism proposed for this severe phenotype is an important role for the 4 integrin for transmigration of progenitors through the stroma. In addition, proliferation of 4-null precursor cells might be decreased, because 4-deficient preB cells that did transmigrate in vitro showed a poor mitotic activity.34 Similar to ß7-deficient mice, the contribution of 4-null T cells to Peyer’s patches is impaired.27 4-Null chimeras that are older than 1 month after birth lack 4-deficient thymocytes in the thymus, although T cell precursors are present in the bone marrow.27 The few peripheral 4-null T cells present show a reduced migration into the inflamed peritoneum.29 Because mice with a disrupted VCAM-1 gene have normal hematopoiesis, the 4-null phenotype is most likely attributable to impaired interactions of 4ß1 with fibronectin.35 Mice with a conditional inactivation of the VCAM-1 gene show reduced number of mature B cells in the BM attributable to a defective migration of lymphocyte to the BM.36,37 In addition, T cell–dependent immune response is impaired.36
Integrins play a central role in leukocyte adhesion and migration. Leukocytes express several integrins in a low-affinity state, ensuring that they do not make inappropriate interactions with ligands normally present in blood or on endothelial cells. To leave the blood, leukocytes attach loosely to activated endothelium via selectins and begin to roll. Chemokines released by the endothelium or the surrounding tissue shift the leukocyte integrin into a high-affinity state that allows binding to endothelial cell adhesion molecules such as ICAMs and VCAM-1, resulting in firm adhesion of the blood cells to the vessel wall. Finally, the leukocytes cross the endothelial cell layer and underlying BM and adhere and migrate within the extravascular tissue.
ß2 integrin is specifically expressed on leukocytes and associates with L (lymphocyte function–associated antigen-1 [LFA-1]), M (Mac-1), X, and D subunits. Important counter-receptors of ß2 integrins are members of the ICAM family.1 However, Mac-1, Xß2, and Dß2 also bind to other proteins: Mac-1 to inactivated complement factor (iC3b), fibrinogen, factor X, Xß2 to iC3b and type I collagen,38 and Dß2 to VCAM-1.39 In addition, Mac-1 and Xß2 can interact specifically with various polysaccharides, such as ß-glucan, mannose, N-acetyl-D-glucosamine, and glucose, which mediate attachment to bacteria.40–42
Humans with a mutation in the ß2 gene develop leukocyte adhesion deficiency type I. These patients have a massive leukocytosis, recurrent bacterial infections, impaired wound healing, and severe gingivitis. Almost no neutrophils extravasate into infected tissues. Mice lacking ß2 integrin display a very similar phenotype.43,44 The degree of neutrophil extravasation, however, is variable and depends on the model of inflammation.43–45 Some neutrophil extravasation processes like the croton oil-induced migration into skin are completely abolished, whereas others, like the sterile peritonitis, still occur. These migrations are perhaps mediated by ß1 integrins. In chronic inflammations, 4ß1 integrin seems to play an important role.46 Another candidate is 9ß1, which is highly expressed on human neutrophils and involved in transendothelial migration in vitro.47 ß2 integrin also plays an important role in T cell proliferation44 and contributes to the accumulation of dendritic cells in the lung.48
LFA-1 and, to a lesser degree, Mac-1 contribute to neutrophil adhesion to endothelium. In a tumor necrosis factor (TNF)-induced air pouch inflammation model, neutrophil migration was equally reduced in ß2-deficient and LFA-1–deficient mice, whereas mice lacking Mac-1 showed a marked increase of neutrophil extravasation.49 In the absence of LFA-1, immune responses against systemic viral infections are normal, but alloantigen triggered T cell proliferation and cytotoxicity are severely impaired, leading to defective host-versus-graft reaction and abrogated tumor rejection.50–52 LFA-1 is also involved in the homing of lymphocytes to peripheral lymph nodes and, to a lesser degree, to mesenteric lymph nodes and Peyer’s patches.53 Mac-1–null neutrophils have an impaired phagocytosis and degranulation, leading to a delayed neutrophil apoptosis.54,55 Furthermore, mast cells were reduced in some but not all locations of Mac-1–deficient mice.56 In an acute glomerulonephritis model, Mac-1–null neutrophils extravasated normally but did not stay in the tissue, apparently because of an absent cytoskeletal rearrangement mediated by Mac-1.57 Unexpectedly, mice lacking Mac-1 or the Mac-1 ligand ICAM-1 are obese, suggesting a role of Mac-1 in the regulation of fat metabolism.58 No knockouts have been reported so far for X and D integrin.
Hemostasis
Platelets express several integrins on their surface, including 2ß1, 5ß1, 6ß1, vß3, and IIbß3, which play different roles during blood coagulation. IIbß3 is crucially important for the aggregation and adhesive spreading of platelets during hemostasis.59 On resting platelets, IIbß3 is present in a low-affinity form. Inside-out signaling triggered by various agonists, including thrombin, ADP, and collagen induces a shift to a high affinity conformation. Activated IIbß3 then binds to fibrinogen, which crosslinks platelets, leading to thrombus formation and finally sealing of wounds. In addition, outside-in signaling induced by ligand binding to IIbß3 results in calcium mobilization, tyrosine phosphorylation of several proteins, including ß3 integrin itself, and additional cytoskeletal rearrangement, which is especially important for stable clot formation.59 This was confirmed in mice with a selective loss of outside-in signaling caused by replacement of the two cytoplasmic tyrosines of the ß3 subunit by phenylalanine residues. These mice are impaired in the late phase of platelet aggregation and in clot retraction in vitro and show an increased rebleeding tendency in vivo.60 Patients having no or only a mutated IIbß3 integrin on platelets suffer from Glanzmann thrombasthenia characterized by impaired platelet aggregation and prolonged bleeding time. The same phenotype was replicated in mice lacking the ß3 or the IIb integrin gene.61,62
When platelets get in contact with injured or diseased blood vessel walls, they tether to the subendothelial matrix through interactions with von Willebrand factor. Integrin 2ß1 was thought to be essential for the subsequent platelet adhesion to collagens, facilitating interactions with the activating platelet collagen receptor glycoprotein VI (GPVI). This hypothesis was based on observations from patients with reduced expression of 2ß1 integrin on platelets who suffered from excessive posttraumatic bleeding and menorrhagia.63,64 In addition, their platelets display profound defects in collagen-induced adhesion/aggregation.65 However, it is presently unclear whether these patients also carried other defects contributing to the pathological condition. A few 2ß1 integrin function–blocking antibodies have been shown to interfere with collagen-induced platelet aggregation.66–68 Surprisingly, however, mice lacking ß1 integrin on megakaryocytes show no significant changes in platelet counts or bleeding time.69 Aggregation of ß1-null platelets on collagen is delayed but not reduced. On the other hand, platelets lacking GPVI cannot activate integrins and consequently fail to adhere to and aggregate on collagen.69 Therefore, GPVI plays the central role in platelet-collagen interactions by activating different adhesive receptors, including 2ß1 integrin. 2ß1 Strengthens adhesion but is not essential for it.
Vasculogenesis and Angiogenesis
Studies of mice carrying integrin-null mutations support the concept that endothelial integrins are involved in the formation and maintenance of the vascular network. Endothelial cells express at least 11 different integrins, including 1ß1, 2ß1, 3ß1, 4ß1, 5ß1, 6ß1, vß1, vß3, vß5, vß8, and 6ß4.
The most severe vascular defect is present in mice lacking the 5 subunit. They have impaired development of the extraembryonic (YS) and embryonic (heart and aorta) vasculature.15 Blood islands form, and hematopoiesis occurs in the YS. Subsequently, the mesoderm and endoderm layers are separated, and the primitive blood cells lie in sacs between the two germ layers and leak into the exocoelomic space. This splitting of the germ layers could be explained by defective cell-matrix interaction or mesoderm defects. All 5-null embryos form heart and blood vessels that contain a few primitive blood cells. The vessels, however, are distended and leak. A very similar but more severe vascular phenotype is present in mice lacking fibronectin,18,70 the major ligand of 5ß1. The fibronectin mutants display variable cardiovascular defects depending on the genetic background.70 On the C57BL/6 background, the defects are less severe, whereas on the 129/Sv background, no hearts have properly formed vessels. In C57BL/6 mutants that form hearts, the myocardial and endocardial cells are disorganized, resulting in a bulbous heart tube. The aorta contains endothelial cells that lack contact with the surrounding mesenchyme, whereas the yolk sac is completely devoid of vessels. On a 129/Sv background, endothelial cells differentiate but fail to assemble into vessels. These findings clearly suggest that 5ß1 is not required for initial vasculogenesis but is necessary for the proper formation and maintenance of blood vessels. Fibronectin, on the other hand, seems necessary for vasculogenesis, suggesting that in the absence of 5, other fibronectin receptors can compensate. Similar to the 5- and fibronectin-null mice, mice lacking vascular endothelial growth factor (VEGF)-R1 (flt-1) have normal hematopoietic progenitors but show impaired blood vessel formation.71 Mice lacking the tie-2 receptor72 or its ligand angiopoetin-173 show defects in the interactions of endothelial cells with the surrounding matrix and mesenchyme. These abnormalities are reminiscent of those observed in 5- and fibronectin-deficient mice, suggesting that these signaling systems cooperate in blood vessel assembly.
Null mutations of other subunits associated with ß1 show milder or no obvious vascular defects. Mice lacking integrin 4 die during embryonic development because of defects in heart and placenta.19 In addition, these mutants lack coronary vessels.19 Because epicardial coronary vessels connect with those in the myocardium, blood from the myocardial vessels leaks, resulting in cardiac hemorrhage in the 4-deficient mice. It is not clear, however, if this is a direct consequence of the loss of 4 or an indirect secondary defect attributable to a loss of the epicardium. A vascular abnormality is also present in 3-null mice. Their glomerular capillaries show reduced branching and a distended lumen.74 Glomerular endothelial cells express 3ß1, and, therefore, the defect could result from an abnormal formation of capillary structure of the glomerulus. It is also possible that the altered capillaries are caused by the failure of podocytes to provide adequate scaffolding, within which the newly formed capillaries would form. Mice lacking the 1 subunit show normal development of the blood vessel system75 but have a reduced tumor angiogenesis.76 This reduction in tumor capillary numbers is caused by overexpression of metalloproteinase 7 (MMP-7) and MMP-9 in the mutants leading to elevation of angiostatin that has been shown to inhibit endothelial cell proliferation in tumors but not during embryogenesis. Isolated 1-null endothelial cells from adult lung, however, show a reduced proliferation on both 1-dependent and -independent substrata, indicating that this response is not restricted to tumor endothelial cells.76 The formation of a normal embryonic vasculature suggests that there are phenotypic differences between embryonic versus adult and tumor endothelial cells. These data demonstrate that 1 integrins regulate MMP expression and that a tightly controlled MMP expression is crucial for angiogenesis. Although MMP synthesis is essential for new blood vessel formation by degrading the ECM and thus facilitating remodelling and invasion, an increased MMP expression can also lead to the release of factors that inhibits cell growth, such as angiostatin.
Endothelial cells express both 6ß1 and 6ß4 integrins. Mice lacking 6 or ß4 integrin show no obvious vascular defects.77,78 Other members of the integrin family or -dystroglycan may compensate for the loss of 6 function. Mice lacking -dystroglycan die before the first vessels form,79 and, therefore, only tissue-specific gene inactivation of the -dystroglycan gene will reveal whether it has a function during vessel formation. Targeted null mutation of the ß1 integrin gene leads to embryonic lethality before the vascular system begins to form. With the use of ß1-null ES cells, however, it is possible to demonstrate an important role for the ß1 subfamily during blood vessel formation. Chimeric mice derived from ß1-null ES cells lack ß1-null endothelial cells in liver,4 indicating that endothelial cells either fail to form or fail to participate in blood vessel formation. In vitro differentiation of ß1-null ES cells into embryoid bodies show that endothelial cells differentiate but initiation of vasculogenesis is significantly delayed.80 In addition, the responsiveness to VEGF is impaired,80 suggesting that VEGF action is upstream of ß1 integrin function. Finally, in ß1-null teratomas, the ß1 mutant ES cells fail to participate in tumor vessel formation, which is in sharp contrast to wild-type ES cells.80
Endothelial cells express at least 4 members of the v-integrin subfamily, vß1, vß3, vß5, and vß8. Numerous studies using blocking antibodies suggested that this family of integrins is of crucial importance for angiogenesis, as shown in chorioallantoic membrane assays,81 tumor models,82 and neovascularization studies of the mouse retina.83,84 The generation and analyses of v-null mice, however, revealed that 20% of the mutants are born alive with no defects in vasculogenesis and angiogenesis.23 Basic endothelial processes of proliferation, migration, tube formation, branching, and basement membrane assembly occur in the mutants. The intracerebral and intestinal vasculature, however, becomes distended and eventually ruptures, resulting in severe hemorrhage. Interestingly, ß8-null mutant mice share many similarities to those of the v mutants, with early defects in placental development and later deficits in formation and stabilization of the vascularization of the central nervous system (Z. Jiangwen and L. Reichardt, personal communication, 2001). Mice lacking ß3 or ß5, two of the v-associated ß subunits, are viable and show no obvious defects in vascular development.61,85 The ß3-null mutants were additionally investigated for defects in postnatal retinal angiogenesis, but no abnormalities were observed.61 In addition, null mutants of many v ligands, including vitronectin,86 tenascin-C,87,88 osteopontin,89 fibrinogen,90 perlecan,91 and von Willebrand factor,92 show no defects in vessel formation.
Skin
The skin is composed of an epidermal and a dermal layer, separated by a basement membrane. The epidermis is made of keratinocytes at different stages of differentiation. The proliferating basal keratinocytes adhere to the basement membrane via specialized adhesion junctions called hemidesmosomes, containing 6ß4 integrin, and via other ECM receptors, including 3ß1 integrin and -dystroglycan. Both 6ß4 and 3ß1 integrins bind laminin 5 (3ß31) of the BM. During differentiation, the keratinocytes lose their integrin expression, detach from the basement membrane, move to the suprabasal layers, and terminally differentiate to form the stratum corneum. Mutations in the 6 or the ß4 gene result in a reduction of hemidesmosomes, causing the epidermolysis bullosa in humans, a severe blistering disease leading in most cases to early postnatal lethality.93 Deletion of the 6 or the ß4 gene in mice leads to a complete absence of hemidesmosomes, a severe detachment of the epidermis and death shortly after birth.77,78,94 Interestingly, the basal lamina is not affected by the loss of 6ß4 integrin.
3-Null mice die shortly after birth because of defects in kidney and lung organogenesis.74 These mice also display mild blisters caused by disruption of the basement membrane organization.95 Keratinocyte-restricted disruption of the ß1 integrin gene during early development causes a similar but more severe phenotype with death shortly after birth, suggesting that 2ß1 or 5ß1, which both are expressed in skin, play an additional role in basement membrane formation and skin homeostasis.96 Skin-specific ablation of the ß1 integrin gene at around birth demonstrated a role of ß1 integrin in the processing of the BM components and in the growth and maintenance of hair follicles. ß1-deficient basal keratinocytes have an aberrant morphology and a reduced proliferation rate, but are still able to terminally differentiate.10 Interestingly, in the absence of both 3 and 6 or ß4 integrin, basal keratinocytes can initially attach to the basal lamina and proliferate, indicating additional adhesion mechanisms.97 A candidate receptor for maintaining proliferation could be -dystroglycan.
The critical importance of laminin-5 as a ligand for 6ß4 integrin is demonstrated by patients with mutations in the laminin subchains 3, ß3, or 2, which develop lethal junctional epidermolysis bullosa.93 Similarly, mice lacking a functional laminin 3 gene have severe blistering and abnormal hemidesmosomes but an ultrastructurally normal basal lamina.98 Adhesion experiments with laminin-5–deficient basement membrane suggested that 3ß1 also interacts with other basement membrane components, in contrast to 6ß4 integrin.
The integrin vß6, which interacts with fibronectin, vitronectin, and tenascin-C, is only expressed on epithelial cells during local injury or inflammation. Mice deficient for ß6 integrin show normal embryonic development and wound healing.99 Surprisingly, however, mutant mice exhibit juvenile baldness attributable to macrophage infiltration of the dermis of the affected areas. Furthermore, ß6-null mice demonstrate an increased airway responsiveness, a hallmark of asthma, and an infiltration of activated B and T cells into the lung. This phenotype was explained by the finding that vß6 can bind to a latent form of the transforming growth factor-ß1 (TGF-ß1), inducing a conformational change in the ligand, which allows its interaction with TGF-ß receptors. Therefore, loss of vß6 reduces the amount of active TGF-ß1 in epithelia, which at least partially mimics a local TGF-ß1–null phenotype.100 Expression of vß6 in injury and inflammation, therefore, leads to increased local activation of TGF-ß1, which, among other effects, modulates inflammatory cell function.
Skeletal Muscle
The ß1 subunit is expressed throughout skeletal muscle development. Initially, muscle precursor cells and fetal muscle express the cytoplasmic ß1A splice variant. After birth, the ß1A splice variant becomes substituted by the ß1D variant.101 During early muscle development, ß1A is expressed with 1, 3, 4, 5, 6, 7, 9, and v. With the exception of the 7 integrin, the other subunits are downregulated around birth. In vitro studies using Drosophila cells revealed an important role for integrins in generating the sarcomeric cytoarchitecture. Normal Drosophila embryo cells fuse and develop sarcomeres in which integrins and actins concentrate at Z-bands. In contrast, integrin-deficient fly cells fail to form sarcomeres.102 In mice, antibody perturbation experiments suggested an important role of ß1 integrin for migration of muscle precursor cells from the dermomyotome to the limbs, fusion of myoblasts into primary and secondary myotubes, and assembly of the contractile proteins/apparatus.103–105 Interaction between 4ß1 on the primary myotubes and VCAM-1 on the secondary myoblasts was suggested to be essential for the formation of the secondary myotubes.105 Such a function for 4 integrin, however, was neither confirmed in 4-null chimeric mice nor in 4-null embryoid bodies.34 In addition, no muscle phenotype was found in the few VCAM-1 null mice that survive the embryonic defects.20,21
5ß1 Integrin is expressed in adhesion plaque–like structures along the myotube during development106 but is downregulated in adult muscle. 5-Null mice die during early development before muscle is formed. 5-Null chimeras with a high contribution of 5-deficient cells to skeletal muscles develop typical alterations resembling muscular dystrophy, including giant muscle fibers, vacuoles, and centrally located nuclei.28 The cause of the muscle degeneration is reduced adhesion and survival of 5-null myoblasts.28
The most abundant integrin in skeletal muscle is 7ß1, which is expressed during all stages of muscle development107,108 and interacts with laminin 2 (2ß11) and laminin 4 (2ß21) in skeletal muscle.109–111 7 Exists in two extracellular (X1 and X2) and three cytoplasmic (A, B, and C) splice variants, which display a tissue-specific and developmentally regulated expression pattern.112–115 Skeletal muscles express 7A, 7B, 7C, and 7X2, whereas 7B, 7X1, and 7X2 are found in the heart. After birth, 7A and 7B concentrate at neuromuscular and myotendinous junctions, whereas 7C is the predominant extrajunctional splice variant.107,113 Mice with a targeted deletion of the 7 integrin develop a progressive muscular dystrophy after birth. The major defect is severe disruption of the myotendinous junctions.116 Mutations in the 7 gene have also been identified in patients suffering from congenital myopathies characterized by delayed motor milestones.117 The genetic findings from mouse and human suggest no role for 7ß1 in myogenesis but a maintenance function on the mature muscle by firmly linking the muscle fibers to the extracellular matrix. Muscle expresses laminin 4 that binds the 7ß1 integrin. Naturally occurring mutations in the laminin 2 gene are found in human and mouse (dy/dy mouse strain) and lead to a congenital muscular dystrophy118 resembling the phenotype produced by loss of 7 integrin expression.
These data demonstrate an important function of 5ß1A and 7ß1D integrins in the maintenance of muscles and show that they cannot compensate each other. However, in ß1-null chimeric mice, ß1-deficient myoblasts migrate, form myotubes, and develop a normal sarcomeric cytoarchitecture in ß1-null chimeric mice.119 The formation of myotubes in ß1-null embryoid bodies is delayed but otherwise normal.119,120 The absence of any obvious muscular dystrophy in the ß1-null chimeric mice could be explained by both a low contribution of ß1-null muscle cells and the presence of wild-type cells, which can functionally compensate. Replacement of the muscle-specific splice variant ß1D by ß1A had no effect on the formation of skeletal muscles.121 No muscle phenotype has been reported from knockouts of 1, 3, 4, 6, 9, and v integrins, respectively.
Heart
Cardiomyocytes express several integrin subunits during development: ß1A, ß1D, 1, 3, 5, 6, 7, and v. Like in the skeletal muscle, after birth, adult cardiac muscle expressed the ß1D variant. Expression of 1, 5, and 6 is downregulated at birth. On the basis of in vitro analysis, integrin-mediated attachment to the ECM has been suggested to be important for controlling growth and differentiation of cardiomyocyte.122 Furthermore, integrins were proposed to function as mechanoreceptors that transform mechanical stimuli into biochemical signals that affect cellular function.122 Several genetic mouse models demonstrate an important function of ß1 integrin in cardiac muscle in vivo. Mice expressing ß1A instead of ß1D in heart develop, without exposure to mechanical stress, mild cardiac defects characterized by an increase in atrial natriuretic peptide (ANP) synthesis. ANP is a vasorelaxant diminishing volume overload and hypertension. Increased levels of ANP have been correlated to, among other things, reduced ventricular function and induction of ventricular hypertrophy. The increased expression of ANP suggests that the ß1A subunit, at least in the heart, is not fully compensating for ß1D.121 Even more severe defects occur when both ß1A and ß1D are absent or functionally inactivated. The areas with ß1-null cardiac muscle cells in the heart of ß1-null chimeras become smaller with time and show signs of degeneration. Ultrastructural analysis revealed alterations in the sarcomeric architecture. In addition, transgenic mice expressing a dominant-negative form of ß1 integrin, in which the extracellular and transmembrane domain of CD4 is fused to cytoplasmic domain of ß1 integrin, show hypertrophic changes in the heart. Mice that express high levels of the transgene die around birth and display a replacement fibrosis.123 Overexpression of a constitutively active form of 5 integrin in the heart results in electrocardiographic abnormalities, cardiomyopathy, and death within one month after birth.124
Skeleton
The vertebrate skeleton develops via two distinct ways: by replacing cartilaginous precursors (endochondral ossification) or by direct development within a mesenchymal tissue (intramembranous ossification). The major cell types of the skeleton, the chondrocytes, the bone depositing osteoblasts, and the bone resorbing osteoclasts, express various integrin receptors at their surfaces. Despite numerous in vitro studies, their function in vivo during skeletogenesis is not well understood. Mice deficient in ß3 integrin produce dysfunctional osteoclasts, leading to osteosclerosis characterized by increased bone mass.125 The mutant osteoclasts fail to form the proper ruffled membrane important for their resorptive function, leading to hypocalcemia in vivo and decreased resorption of whale dentin in vitro. Furthermore, ß3-deficient osteoclasts do not spread in culture and lack the characteristic actin rings, suggesting that vß3-mediated signals are important for the organization of cytoskeleton in these cells.
The most severe skeletal abnormalities have been identified in 3-/-6-/- double-knockout mice.126 They display exencephaly attributable to the failure of neural tube closure, kinked tail, and limb anomalies characterized by shortening, abnormal shape, lack of digit separation, and fusion of phalanges between digits 2 and 3. Detailed analyses revealed discontinuity of the surface ectoderm of the distal limb and defective formation of a specialized limb bud epithelial structure, called apical ectodermal ridge (AER). AER is located at the tip of the bud and is involved in the control of limb outgrowth and differentiation. Both 3 and 6 integrin chains are expressed in this region, and a lack of both integrins results in structural disorganization and reduced proliferation of the ridge cells. Because single 3 or 6 mutants do not show such defects, the observations suggest that the presence of both integrin chains is crucial for the organization and proper function of AER and reveal the synergistic actions of these integrins in limb morphogenesis. Similar abnormalities of the distal limbs are present in the laminin 5 knockout mice.127 Altogether, these observations indicate that 3 and 6 integrins are the major cell-surface receptors for laminins containing 5 chains in the distal limb ectoderm.
Transgenic mice expressing a dominant-negative ß1 integrin subunit under the control of the osteoblast-specific osteocalcin promoter show impaired membranous bone formation.128 The phenotype is characterized by a decreased rate of cortical bone formation and reduced bone mass of cortical and flat bones in young animals, indicating the importance of ß1 integrin in osteoblast function. The defect of flat bones was normalized in older males but not in females, suggesting sex-specific differences in adult animals.
Kidney
So far, two integrins, 3ß1 and 8ß1, have been shown to be crucial for kidney development. In 3-/- mutant mice, the glomerular basement membrane of the kidney is disorganized and glomerular podocytes are unable to form mature foot processes, suggesting that 3 integrin might be important for basal membrane organization. In addition, these mutant mice have a lung defect with reduced branching of the conducting airway74 and show an alteration of the basal membrane organization of the submandibular gland.129
Inactivation of the 8 integrin leads to a failure in kidney development, with different levels of severity ranging from a reduction of kidney size to a complete loss of kidneys.130 The kidney defect is characterized by abnormal growth of the ureteric bud and abnormal branching and formation of the ureteric epithelium. Fibronectin, tenascin-C, and vitronectin bind to 8ß1. However, they seem not to be involved in the phenotype, because they are not detectably expressed during this stage of kidney development. Osteopontin can also bind 8ß1 and has been proposed to mediate this interaction. Osteopontin-null mice, however, are normal and develop no apparent phenotype in the kidney.131,132
Most integrin 8-null mice die soon after birth, but a few survive until adulthood. These mice are deaf and have balance defects attributable to a structural inner-ear defect, indicating a role of 8ß1 integrin and its ligand fibronectin in hair-cell differentiation and function.133
Brain
Evidence coming from fly and worm suggest a critical role for the integrin family during brain development and maintaining brain function.134 This was also confirmed in mice. 3-Null mice display a defect in neuron migration and a disorganized layering of the cerebral cortex, suggesting that this integrin is involved in radial neuronal cell migration.135 A very similar phenotype is observed in reeler mice, which lack the extracellular matrix protein reelin. In these mutant mice, migration of Cajal-Retzius cells is impaired, leading to an abnormal lamination of the cerebral cortex. A recent study showed that 3ß1 integrin can bind reelin.136 This interaction may provide a stop signal and arrest neuronal migration.
6-Null mice have abnormalities in the laminar organization of the developing cerebral cortex and retina, ectopic neuroblastic outgrowth on the brain surface and in the eye, and an abnormal laminin deposition.137 In the 3-/-6-/- double-knockout mice, the cortical disorganization appears earlier and is more severe, likely because of an additive effect of the two mutations. Ablation of the laminin 5 gene leads also to a brain phenotype similar to the 3-/-6-/- double knockouts. In addition, the 3-/-6-/- mutants have several other abnormalities, including exencephaly, syndactyly, and kidney defects.126,127,138
Axotomy leads to an increased expression of 7ß1 integrin on axons and growth cones during peripheral nerve regeneration. An impaired axonal regeneration has been reported in 7-null mutants, suggesting that this integrin plays a role in this process.139
Signaling
Integrin-mediated adhesion results in the activation of various signaling cascades inside the cell, including activation of tyrosine kinases like focal adhesion kinase (FAK) and Src, serine/threonine kinases like mitogen activated protein kinase (MAPK), and small G proteins.3,140 Direct evidence for signaling defects in integrin-deficient mice is scarce. In 7-null mice, a constitutive activation of c-Raf-1 kinase was observed in muscle, suggesting that 7ß1 integrin may be involved in the negative control of this pathway.141 However, this finding could also be caused indirectly by the muscle degeneration observed in these mice. Analysis of the inner ear development in 8-null mice revealed a defect in stereocilia formation correlating with a loss of FAK at the cell membrane.133
Cell cultures studies revealed that integrin-mediated signals are involved in cell proliferation, cell survival, prevention of apoptosis (also called anoikis), and cell differentiation.142 Presently, it is not clear to what degree the integrin signaling observed in vitro also has a role in vivo. The observations collected so far suggest an involvement of integrins in regulating cell proliferation and programmed cell death in vivo.
Several integrin-null mice show reduced proliferation of certain cell populations. Mice lacking 3 and 6 integrin have a reduction of cell proliferation in the AER,126 and mice lacking ß1 integrin in keratinocytes lose proliferating hair matrix cells and display a reduced proliferation of basal keratinocytes.10 Deletion of the 1 gene results in decreased proliferation of dermal fibroblasts.143 In vitro culture of these fibroblasts demonstrated a failure to recruit and activate the adaptor protein Shc, which triggers the MAPK activation cascade leading to cell proliferation. In a dominant-negative approach, the cytoplasmic and transmembrane domain of ß1 integrin was fused to the extracellular domain of CD4, which interferes with endogenous ß1 integrin function in vitro. Expression of such a chimeric protein in the mammary gland of transgenic mice results in decreased proliferation, increased apoptosis, and impaired differentiation of the mammary epithelial cells.144 Additional biochemical analysis of these mice revealed no change in FAK activation in the mammary gland but a significant decrease in the phosphorylation of Shc, Grb2, Akt, c-Jun N-terminal kinase, and extracellular signal–regulated kinase.145 Lack of the ß4 integrin cytoplasmic domain has been shown to reduce proliferation in the skin and intestine,146 which agrees with in vitro data showing that ß4 integrin is able to bind and activate Shc.
Cell survival defects have been reported in some integrin-null mice. For instance, 5 integrin was shown to be important for the survival of neural crest cells in vivo,17 and 3-/-6-/- mice have syndactyly resulting from an impaired cell death of interdigital cells.126 On the other hand, loss of ß1 integrin–mediated adhesion of basal keratinocytes does not result in cell death, in contrast to expectations from cell culture experiments.10
Concerning differentiation processes, so far gene ablation approaches revealed only a minor role for integrins. Absence of ß1 integrin does not interfere with differentiation of neurons and neural crest–derived cells,4 fetal hematopoietic cells,26 or keratinocytes.10 Double knockouts for 3 and 6 integrin show normal keratinocyte differentiation, despite the absence of the major integrin receptors 3ß1 and 6ß4.126 In vitro myoblast differentiation and fusion occurs independently of ß1 integrin but is delayed.119 A similar delay was found in blood vessel formation in ß1-null embryoid bodies.80 Such a delay could be attributable to the absence of ß1 integrin or the experimental design that does not reflect the in vivo conditions, eg, growth factors that are absent in fetal calf serum but not in vivo or absence of complex matrices in vitro. On the other hand, teratomas using ß1-null cells never give rise to an endothelial cell population, suggesting that ß1 integrin could be involved during their differentiation or survival.80
Future
Analysis of integrin function by gene-targeted mice often confirmed but sometimes also contradicted previous results obtained by antibody or peptide inhibition studies. For instance, blocking vß3 function by inhibitory antibodies suggested an essential role of vß3 integrin in angiogenesis. However, both v and ß3 knockout mice show blood vessel formation. Similarly, a few 2 blocking antibodies prevent collagen-induced platelet aggregation, whereas deletion of ß1 integrin on platelets revealed only a minor and clearly dispensable role for 2ß1 during this process. One obvious disadvantage of antibodies is that they do not completely block protein function, whereas a targeted gene disruption leads to a complete loss of the protein. In addition, antibodies might have unexpected side effects by steric hindrance of other ligand-receptor interactions or only partial inhibition of the integrin signaling. However, constitutive gene knockout also has disadvantages. The mutated mouse might react to the loss of a protein by upregulating the activity or expression of other molecules, thus compensating the defect. Because totipotent embryonic cells, at least theoretically, have a high capacity for compensation, this risk is real in constitutive knockouts, and compensation has already been demonstrated on several occasions. A way to reduce the chance of compensation is to induce the knockout in more differentiated cells, which are less able to change their expression pattern. This is possible using the cre/loxP system generating mice with tissue restricted or inducible gene deletions.10,26,69,96 The generation of mice carrying floxed integrin genes to induce cell type–specific deletions, but also the introduction of subtle mutations into the extracellular and intracellular domain of integrin subunits and the interbreeding of integrin-null mice to create double and triple mutant animals, will additionally advance our understanding of how integrins function in vivo. In addition, the mutant mice will allow the establishment of cell lines that can be used to study in vivo observations at a molecular level.
More information about the role of integrins in signaling in vivo will come from the analysis of mutant tissues with antibodies specific for activated forms of signaling molecules, from knockin mice carrying subtle mutations of the integrin molecules interfering specifically with certain in vitro signaling functions, from knockouts of integrin-associated proteins, and from the rescue of integrin-null mice with transgenes encoding activated forms of signal transduction molecules suspected to act downstream of the respective integrins.
|
Acknowledgments |
|---|
This work was supported by the Craaford Foundation (E.G.) and the Swedish National Research Foundation (R.F. and C.B.). D.B. is a Wenner-Gren fellow. We are grateful to Drs Z. Jiangwen and L. Reichardt for sharing information before publication. We thank Drs T. Sakai, Kamin Johnson, and Michael Dictor for critical reading the manuscript.
|
Footnotes |
|---|
*Both authors contributed equally to this work.
Received March 6, 2001; accepted June 20, 2001.
|
References |
|---|
|
TopAbstractIntroductionEarly Mouse DevelopmentReferences |
|---|
1. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem. . 2000; 275: 21785–21788.
2. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. . 1992; 69: 11–25.[Medline] [Order article via Infotrieve]
3. Giancotti FG. Complexity and specificity of integrin signalling. Nat Cell Biol. . 2000; 2: E13–E14.[Medline] [Order article via Infotrieve]
4.
Fässler R, Meyer M. Consequences of lack of ß1 integrin gene expression in mice. Genes Dev. . 1995; 9: 1896–1908.
5.
Stephens LE, Sutherland AE, Klimanskaya IV, Andrieux A, Meneses J, Pedersen RA, Damsky CH. Deletion of ß1 integrins in mice results in inner cell mass failure and peri-implantation lethality. Genes Dev. . 1995; 9: 1883–1895.
6. Brakebusch C, Hirsch E, Potocnik A, Fässler R. Genetic analysis of ß1 integrin function: confirmed, new and revised roles for a crucial family of cell adhesion molecules. J Cell Sci. . 1997; 110: 2895–2904.[Abstract]
7. Coucouvanis E, Martin GR. Signals for death and survival: a two-step mechanism for cavitation in the vertebrate embryo. Cell. . 1995; 83: 279–287.[Medline] [Order article via Infotrieve]
8. Aumailley M, Pesch M, Tunggal L, Gaill F, Fassler R. Altered synthesis of laminin 1 and absence of basement membrane component deposition in ß1 integrin-deficient embryoid bodies. J Cell Sci. . 2000; 113 (pt 2):259–268.[Abstract]
9. Bagutti C, Wobus AM, Fassler R, Watt FM. Differentiation of embryonal stem cells into keratinocytes: comparison of wild-type and ß1 integrin-deficient cells. Dev Biol. . 1996; 179: 184–196.[Medline] [Order article via Infotrieve]
10. Brakebusch C, Grose R, Quondamatteo F, Ramirez A, Jorcano JL, Pirro A, Svensson M, Herken R, Sasaki T, Timpl R, Werner S, Fassler R. Skin and hair follicle integrity is crucially dependent on ß1 integrin expression on keratinocytes. EMBO J. . 2000; 19: 3990–4003.[Medline] [Order article via Infotrieve]
11. Henry MD, Satz JS, Brakebusch C, Costell M, Gustafsson E, Fassler R, Campbell KP. Distinct roles for dystroglycan, ß1 integrin and perlecan in cell surface laminin organization. J Cell Sci. . 2001; 114: 1137–1144.[Abstract]
12. Sasaki T, Forsberg E, Bloch W, Addicks K, Fassler R, Timpl R. Deficiency of ß1 integrins in teratoma interferes with basement membrane assembly and laminin-1 expression. Exp Cell Res. . 1998; 238: 70–81.[Medline] [Order article via Infotrieve]
13.
Smyth N, Vatansever HS, Murray P, Meyer M, Frie C, Paulsson M, Edgar D. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol. . 1999; 144: 151–160.
14.
Murray P, Edgar D. Regulation of programmed cell death by basement membranes in embryonic development. J Cell Biol. . 2000; 150: 1215–1221.
15.
Yang JT, Rayburn H, Hynes RO. Embryonic mesodermal defects in 5 integrin-deficient mice. Development. . 1993; 119: 1093–1105.[Abstract]
16. Yang JT, Bader BL, Kreidberg JA, Ullman-Cullere M, Trevithick JE, Hynes RO. Overlapping and independent functions of fibronectin receptor integrins in early mesodermal development. Dev Biol. . 1999; 215: 264–277.[Medline] [Order article via Infotrieve]
17.
Goh KL, Yang JT, Hynes RO. Mesodermal defects and cranial neural crest apoptosis in 5 integrin-null embryos. Development. . 1997; 124: 4309–4319.[Abstract]
18. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. . 1993; 119: 1079–1091.[Abstract]
19.
Yang JT, Rayburn H, Hynes RO. Cell adhesion events mediated by 4 integrins are essential in placental and cardiac development. Development. . 1995; 121: 549–560.[Abstract]
20.
Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, Cybulsky MI. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. . 1995; 9: 1–14.
21. Kwee L, Baldwin HS, Shen HM, Stewart CL, Buck C, Buck CA, Labow MA. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development. . 1995; 121: 489–503.[Abstract]
22.
Eliceiri BP, Cheresh DA. Role of v integrins during angiogenesis. Cancer J Sci Am. . 2000; 6 (suppl 3): S245–S249.
23.
Bader BL, Rayburn H, Crowley D, Hynes RO. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all v integrins. Cell. . 1998; 95: 507–519.[Medline]
[Order article via Infotrieve]
24. Gustafsson E, Fassler R. Insights into extracellular matrix functions from mutant mouse models. Exp Cell Res. . 2000; 261: 52–68.[Medline] [Order article via Infotrieve]
25. Hirsch E, Iglesias A, Potocnik AJ, Hartmann U, Fassler R. Impaired migration but not differentiation of haematopoietic stem cells in the absence of ß1 integrins. Nature. . 1996; 380: 171–175.[Medline] [Order article via Infotrieve]
26. Potocnik AJ, Brakebusch C, Fassler R. Fetal and adult hematopoietic stem cells require ß1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity. . 2000; 12: 653–663.[Medline] [Order article via Infotrieve]
27.
Arroyo AG, Yang JT, Rayburn H, Hynes RO. Differential requirements for 4 integrins during fetal and adult hematopoiesis. Cell. . 1996; 85: 997–1008.[Medline]
[Order article via Infotrieve]
28.
Taverna D, Disatnik MH, Rayburn H, Bronson RT, Yang J, Rando TA, Hynes RO. Dystrophic muscle in mice chimeric for expression of 5 integrin. J Cell Biol. . 1998; 143: 849–859.
29.
Arroyo AG, Taverna D, Whittaker CA, Strauch UG, Bader BL, Rayburn H, Crowley D, Parker CM, Hynes RO. In vivo roles of integrins during leukocyte development and traffic: insights from the analysis of mice chimeric for 5, v, and 4 integrins. J Immunol. . 2000; 165: 4667–4675.
30. Wagner N, Lohler J, Kunkel EJ, Ley K, Leung E, Krissansen G, Rajewsky K, Muller W. Critical role for ß7 integrins in formation of the gut-associated lymphoid tissue. Nature. . 1996; 382: 366–370.[Medline] [Order article via Infotrieve]
31. Pabst O, Forster R, Lipp M, Engel H, Arnold HH. NKX2.3 is required for MAdCAM-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue. EMBO J. . 2000; 19: 2015–2023.[Medline] [Order article via Infotrieve]
32.
Schon MP, Arya A, Murphy EA, Adams CM, Strauch UG, Agace WW, Marsal J, Donohue JP, Her H, Beier DR, Olson S, Lefrancois L, Brenner MB, Grusby MJ, Parker CM. Mucosal T lymphocyte numbers are selectively reduced in integrin E (CD103)-deficient mice. J Immunol. . 1999; 162: 6641–6649.
33. Wagner N, Lohler J, Tedder TF, Rajewsky K, Muller W, Steeber DA. L-selectin, and ß7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes. Eur J Immunol. . 1998; 28: 3832–3839.[Medline] [Order article via Infotrieve]
34.
Arroyo AG, Yang JT, Rayburn H, Hynes RO. 4 Integrins regulate the proliferation/differentiation balance of multilineage hematopoietic progenitors in vivo. Immunity. . 1999; 11: 555–566.[Medline]
[Order article via Infotrieve]
35. Friedrich C, Cybulsky MI, Gutierrez-Ramos JC. Vascular cell adhesion molecule-1 expression by hematopoiesis-supporting stromal cells is not essential for lymphoid or myeloid differentiation in vivo or in vitro. Eur J Immunol. . 1996; 26: 2773–2780.[Medline] [Order article via Infotrieve]
36.
Leuker CE, Labow M, Muller W, Wagner N. Neonatally induced inactivation of the vascular cell adhesion molecule 1 gene impairs B cell localization and T cell-dependent humoral immune response. J Exp Med. . 2001; 193: 755–768.
37.
Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. . 2001; 193: 741–754.
38.
Garnotel R, Rittie L, Poitevin S, Monboisse JC, Nguyen P, Potron G, Maquart FX, Randoux A, Gillery P. Human blood monocytes interact with type I collagen through xß2 integrin (CD11c-CD18, gp150-95). J Immunol. . 2000; 164: 5928–5934.
39.
Van der Vieren M, Crowe DT, Hoekstra D, Vazeux R, Hoffman PA, Grayson MH, Bochner BS, Gallatin WM, Staunton DE. The leukocyte integrin Dß2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. J Immunol. . 1999; 163: 1984–1990.
40.
Ingalls RR, Golenbock DT. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J Exp Med. . 1995; 181: 1473–1479.
41.
Schlesinger LS, Horwitz MA. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN- activation inhibits complement receptor function and phagocytosis of this bacterium. J Immunol. . 1991; 147: 1983–1994.[Abstract]
42.
Xia Y, Vetvicka V, Yan J, Hanikyrova M, Mayadas T, Ross GD. The ß -glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J Immunol. . 1999; 162: 2281–2290.
43.
Mizgerd JP, Kubo H, Kutkoski GJ, Bhagwan SD, Scharffetter-Kochanek K, Beaudet AL, Doerschuk CM. Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice. J Exp Med. . 1997; 186: 1357–1364.
44.
Scharffetter-Kochanek K, Lu H, Norman K, van Nood N, Munoz F, Grabbe S, McArthur M, Lorenzo I, Kaplan S, Ley K, Smith CW, Montgomery CA, Rich S, Beaudet AL. Spontaneous skin ulceration and defective T cell function in CD18 null mice. J Exp Med. . 1998; 188: 119–131.
45.
Jung U, Ley K. Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J Immunol. . 1999; 162: 6755–6762.
46.
Johnston B, Kubes P. The 4-integrin: an alternative pathway for neutrophil recruitment? Immunol Today. . 1999; 20: 545–550.[Medline]
[Order article via Infotrieve]
47.
Taooka Y, Chen J, Yednock T, Sheppard D. The integrin 9ß1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol. . 1999; 145: 413–420.
48.
Schneeberger EE, Vu Q, LeBlanc BW, Doerschuk CM. The accumulation of dendritic cells in the lung is impaired in CD18-/- but not in ICAM-1-/- mutant mice. J Immunol. . 2000; 164: 2472–2478.
49.
Ding ZM, Babensee JE, Simon SI, Lu H, Perrard JL, Bullard DC, Dai XY, Bromley SK, Dustin ML, Entman ML, Smith CW, Ballantyne CM. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J Immunol. . 1999; 163: 5029–5038.
50.
Schmits R, Kundig TM, Baker DM, Shumaker G, Simard JJ, Duncan G, Wakeham A, Shahinian A, van der Heiden A, Bachmann MF, Ohashi PS, Mak TW, Hickstein DD. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J Exp Med. . 1996; 183: 1415–1426.
51. Shier P, Otulakowski G, Ngo K, Panakos J, Chourmouzis E, Christjansen L, Lau CY, Fung-Leung WP. Impaired immune responses toward alloantigens and tumor cells but normal thymic selection in mice deficient in the ß2 integrin leukocyte function-associated antigen-1. J Immunol. . 1996; 157: 5375–5386.[Abstract]
52.
Shier P, Ngo K, Fung-Leung WP. Defective CD 8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling. J Immunol. . 1999; 163: 4826–4832.
53.
Berlin-Rufenach C, Otto F, Mathies M, Westermann J, Owen MJ, Hamann A, Hogg N. Lymphocyte migration in lymphocyte function-associated antigen (LFA)-1-deficient mice. J Exp Med. . 1999; 189: 1467–1478.
54. Coxon A, Rieu P, Barkalow FJ, Askari S, Sharpe AH, von Andrian UH, Arnaout MA, Mayadas TN. A novel role for the ß2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity. . 1996; 5: 653–666.[Medline] [Order article via Infotrieve]
55. Lu H, Smith CW, Perrard J, Bullard D, Tang L, Shappell SB, Entman ML, Beaudet AL, Ballantyne CM. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J Clin Invest. . 1997; 99: 1340–1350.[Medline] [Order article via Infotrieve]
56.
Rosenkranz AR, Coxon A, Maurer M, Gurish MF, Austen KF, Friend DS, Galli SJ, Mayadas TN. Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J Immunol. . 1998; 161: 6463–6467.
57.
Tang T, Rosenkranz A, Assmann KJM, Goodman MJ, Gutierrez-Ramos JC, Carroll MC, Cotran RS, Mayadas TN. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fc receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J Exp Med. . 1997; 186: 1853–1863.
58.
Dong ZM, Gutierrez-Ramos JC, Coxon A, Mayadas TN, Wagner DD. A new class of obesity genes encodes leukocyte adhesion receptors. Proc Natl Acad Sci U S A. . 1997; 94: 7526–7530.
59.
Shattil SJ, Kashiwagi H, Pampori N. Integrin signaling: the platelet paradigm. Blood. . 1998; 91: 2645–2657.
60.
Law DA, DeGuzman FR, Heiser P, Ministri-Madrid K, Killeen N, Phillips DR. Integrin cytoplasmic tyrosine motif is required for outside-in IIbß3 signalling and platelet function. Nature. . 1999; 401: 808–811.[Medline]
[Order article via Infotrieve]
61. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, Ullman-Cullere M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. ß3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. . 1999; 103: 229–238.[Medline] [Order article via Infotrieve]
62.
Tronik-Le Roux D, Roullot V, Poujol C, Kortulewski T, Nurden P, Marguerie G. Thrombasthenic mice generated by replacement of the integrin IIb gene: demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitment. Blood. 2000;96:1399–1408.
63.
Kehrel B, Balleisen L, Kokott R, Mesters R, Stenzinger W, Clemetson KJ, van de Loo J. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood. . 1988; 71: 1074–1078.
64. Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature. . 1985; 318: 470–472.[Medline] [Order article via Infotrieve]
65.
Santoro SA. Platelet surface collagen receptor polymorphisms: variable receptor expression and thrombotic/hemorrhagic risk. Blood. . 1999; 93: 3575–3577.
66.
Kamiguti AS, Markland FS, Zhou Q, Laing GD, Theakston RD, Zuzel M. Proteolytic cleavage of the ß1 subunit of platelet 2ß1 integrin by the metalloproteinase jararhagin compromises collagen-stimulated phosphorylation of pp72. J Biol Chem. . 1997; 272: 32599–32605.
67.
Saelman EU, Nieuwenhuis HK, Hese KM, de Groot PG, Heijnen HF, Sage EH, Williams S, McKeown L, Gralnick HR, Sixma JJ. Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (2ß1-integrin). Blood. . 1994; 83: 1244–1250.
68.
Verkleij MW, Morton LF, Knight CG, de Groot PG, Barnes MJ, Sixma JJ. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via 2ß1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces. Blood. . 1998; 91: 3808–3816.
69.
Nieswandt B, Brakebusch C, Bergmeier W, Schulte V, Bouvard D, Mokhtari-Nejad R, Lindhout T, Heemskerk JW, Zirngibl H, Fassler R. Glycoprotein VI but not 2ß1 integrin is essential for platelet interaction with collagen. EMBO J. . 2001; 20: 2120–2130.[Medline]
[Order article via Infotrieve]
70.
George EL, Baldwin HS, Hynes RO. Fibronectins are essential for heart and blood vessel morphogenesis but are dispensable for initial specification of precursor cells. Blood. . 1997; 90: 3073–3081.
71. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. . 1995; 376: 66–70.[Medline] [Order article via Infotrieve]
72. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. . 1995; 376: 70–74.[Medline] [Order article via Infotrieve]
73. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. . 1996; 87: 1171–1180.[Medline] [Order article via Infotrieve]
74.
Kreidberg JA, Donovan MJ, Goldstein SL, Rennke H, Shepherd K, Jones RC, Jaenisch R. 3ß1 integrin has a crucial role in kidney and lung organogenesis. Development. . 1996; 122: 3537–3547.[Abstract]
75.
Gardner H, Kreidberg J, Koteliansky V, Jaenisch R. Deletion of integrin 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol. . 1996; 175: 301–313.[Medline]
[Order article via Infotrieve]
76.
Pozzi A, Moberg PE, Miles LA, Wagner S, Soloway P, Gardner HA. Elevated matrix metalloprotease and angiostatin levels in integrin 1 knockout mice cause reduced tumor vascularization. Proc Natl Acad Sci U S A. . 2000; 97: 2202–2207.
77.
Georges-Labouesse E, Messaddeq N, Yehia G, Cadalbert L, Dierich A, Le Meur M. Absence of integrin 6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet. . 1996; 13: 370–373.[Medline]
[Order article via Infotrieve]
78. van der Neut R, Krimpenfort P, Calafat J, Niessen CM, Sonnenberg A. Epithelial detachment due to absence of hemidesmosomes in integrin ß4 null mice. Nat Genet. . 1996; 13: 366–369.[Medline] [Order article via Infotrieve]
79.
Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell KP. Dystroglycan is essential for early embryonic development: disruption of Reichert’s membrane in Dag1-null mice. Hum Mol Genet. . 1997; 6: 831–841.
80.
Bloch W, Forsberg E, Lentini S, Brakebusch C, Martin K, Krell HW, Weidle UH, Addicks K, Fassler R. ß1 integrin is essential for teratoma growth and angiogenesis. J Cell Biol. . 1997; 139: 265–278.
81.
Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin vß3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. . 1994; 79: 1157–1164.[Medline]
[Order article via Infotrieve]
82.
Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH, Cheresh DA. Antiintegrin vß3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. . 1995; 96: 1815–1822.
83.
Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA. Definition of two angiogenic pathways by distinct v integrins. Science. . 1995; 270: 1500–1502.
84. Hammes HP, Brownlee M, Jonczyk A, Sutter A, Preissner KT. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med. . 1996; 2: 529–533.[Medline] [Order article via Infotrieve]
85.
Huang X, Griffiths M, Wu J, Farese RV Jr, Sheppard D. Normal development, wound healing, and adenovirus susceptibility in ß5-deficient mice. Mol Cell Biol. . 2000; 20: 755–759.
86.
Zheng X, Saunders TL, Camper SA, Samuelson LC, Ginsburg D. Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci U S A. . 1995; 92: 12426–12430.
87.
Forsberg E, Hirsch E, Frohlich L, Meyer M, Ekblom P, Aszodi A, Werner S, Fassler R. Skin wounds and severed nerves heal normally in mice lacking tenascin-C. Proc Natl Acad Sci U S A. . 1996; 93: 6594–6599.
88.
Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S. Mice develop normally without tenascin. Genes Dev. . 1992; 6: 1821–1831.
89. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest. . 1998; 101: 1468–1478.[Medline] [Order article via Infotrieve]
90.
Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter S, Degen JL. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. . 1995; 9: 2020–2033.
91.
Costell M, Gustafsson E, Aszodi A, Morgelin M, Bloch W, Hunziker E, Addicks K, Timpl R, Fassler R. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol. . 1999; 147: 1109–1122.
92.
Denis C, Methia N, Frenette PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci U S A. . 1998; 95: 9524–9529.
93. Pulkkinen L, Uitto J. Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol. . 1999; 18: 29–42.[Medline] [Order article via Infotrieve]
94.
Dowling J, Yu QC, Fuchs E. ß4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol. . 1996; 134: 559–572.
95.
DiPersio CM, Hodivala-Dilke KM, Jaenisch R, Kreidberg JA, Hynes RO. 3ß1 Integrin is required for normal development of the epidermal basement membrane. J Cell Biol. . 1997; 137: 729–742.
96.
Raghavan S, Bauer C, Mundschau G, Li Q, Fuchs E. Conditional ablation of ß1 integrin in skin: severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. J Cell Biol. . 2000; 150: 1149–1160.
97.
DiPersio CM, van Der Neut R, Georges-Labouesse E, Kreidberg JA, Sonnenberg A, Hynes RO. 3ß1 and 6ß4 integrin receptors for laminin-5 are not essential for epidermal morphogenesis and homeostasis during skin development. J Cell Sci. . 2000; 113: 3051–3062.[Abstract]
98.
Ryan MC, Lee K, Miyashita Y, Carter WG. Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol. . 1999; 145: 1309–1323.
99.
Huang XZ, Wu JF, Cass D, Erle DJ, Corry D, Young SG, Farese RV, Sheppard D. Inactivation of the integrin ß6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol. . 1996; 133: 921–928.
100.
Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D. The integrin vß6 binds and activates latent TGF ß1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. . 1999; 96: 319–328.[Medline]
[Order article via Infotrieve]
101.
Belkin AM, Zhidkova NI, Balzac F, Altruda F, Tomatis D, Maier A, Tarone G, Koteliansky VE, Burridge K. ß1D integrin displaces the ß1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells. J Cell Biol. . 1996; 132: 211–226.
102. Volk T, Fessler LI, Fessler JH. A role for integrin in the formation of sarcomeric cytoarchitecture. Cell. . 1990; 63: 525–536.[Medline] [Order article via Infotrieve]
103. Jaffredo T, Horwitz AF, Buck CA, Rong PM, Dieterlen-Lievre F. Myoblast migration specifically inhibited in the chick embryo by grafted CSAT hybridoma cells secreting an anti-integrin antibody. Development. . 1988; 103: 431–446.[Abstract]
104. Menko AS, Boettiger D. Occupation of the extracellular matrix receptor, integrin, is a control point for myogenic differentiation. Cell. . 1987; 51: 51–57.[Medline] [Order article via Infotrieve]
105. Rosen GD, Sanes JR, LaChance R, Cunningham JM, Roman J, Dean DC. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell. . 1992; 69: 1107–1119.[Medline] [Order article via Infotrieve]
106.
Lakonishok M, Muschler J, Horwitz AF. The 5ß1 integrin associates with a dystrophin-containing lattice during muscle development. Dev Biol. . 1992; 152: 209–220.[Medline]
[Order article via Infotrieve]
107.
Bao ZZ, Lakonishok M, Kaufman S, Horwitz AF. 7ß1 integrin is a component of the myotendinous junction on skeletal muscle. J Cell Sci. . 1993; 106: 579–589.[Abstract]
108.
George-Weinstein M, Foster RF, Gerhart JV, Kaufman SJ. In vitro and in vivo expression of 7 integrin and desmin define the primary and secondary myogenic lineages. Dev Biol. . 1993; 156: 209–229.[Medline]
[Order article via Infotrieve]
109.
Schober S, Mielenz D, Echtermeyer F, Hapke S, Poschl E, von der Mark H, Moch H, von der Mark K. The role of extracellular and cytoplasmic splice domains of 7-integrin in cell adhesion and migration on laminins. Exp Cell Res. . 2000; 255: 303–313.[Medline]
[Order article via Infotrieve]
110.
von der Mark H, Durr J, Sonnenberg A, von der Mark K, Deutzmann R, Goodman SL. Skeletal myoblasts utilize a novel ß1-series integrin and not 6ß1 for binding to the E8 and T8 fragments of laminin. J Biol Chem. . 1991; 266: 23593–23601.
111. Yao CC, Ziober BL, Sutherland AE, Mendrick DL, Kramer RH. Laminins promote the locomotion of skeletal myoblasts via the ß7 integrin receptor. J Cell Sci. . 1996; 109: 3139–3150.[Abstract]
112.
Collo G, Starr L, Quaranta V. A new isoform of the laminin receptor integrin 7ß1 is developmentally regulated in skeletal muscle. J Biol Chem. . 1993; 268: 19019–19024.
113.
Martin PT, Kaufman SJ, Kramer RH, Sanes JR. Synaptic integrins in developing, adult, and mutant muscle: selective association of 1, 7A, and 7B integrins with the neuromuscular junction. Dev Biol. . 1996; 174: 125–139.[Medline]
[Order article via Infotrieve]
114.
Song WK, Wang W, Sato H, Bielser DA, Kaufman SJ. Expression of 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases. J Cell Sci. . 1993; 106: 1139–1152.[Abstract]
115.
Ziober BL, Vu MP, Waleh N, Crawford J, Lin CS, Kramer RH. Alternative extracellular and cytoplasmic domains of the integrin 7 subunit are differentially expressed during development. J Biol Chem. . 1993; 268: 26773–26783.
116.
Mayer U, Saher G, Fassler R, Bornemann A, Echtermeyer F, von der Mark H, Miosge N, Poschl E, von der Mark K. Absence of integrin 7 causes a novel form of muscular dystrophy. Nat Genet. . 1997; 17: 318–323.[Medline]
[Order article via Infotrieve]
117.
Hayashi YK, Chou FL, Engvall E, Ogawa M, Matsuda C, Hirabayashi S, Yokochi K, Ziober BL, Kramer RH, Kaufman SJ, Ozawa E, Goto Y, Nonaka I, Tsukahara T, Wang JZ, Hoffman EP, Arahata K. Mutations in the integrin 7 gene cause congenital myopathy. Nat Genet. . 1998; 19: 94–97.[Medline]
[Order article via Infotrieve]
118.
Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ. Altered expression of the 7ß1 integrin in human and murine muscular dystrophies. J Cell Sci. . 1997; 110: 2873–2881.[Abstract]
119. Hirsch E, Lohikangas L, Gullberg D, Johansson S, Fassler R. Mouse myoblasts can fuse and form a normal sarcomere in the absence of ß1 integrin expression. J Cell Sci. . 1998; 111: 2397–2409.[Abstract]
120. Rohwedel J, Guan K, Zuschratter W, Jin S, Ahnert-Hilger G, Furst D, Fassler R, Wobus AM. Loss of ß1 integrin function results in a retardation of myogenic, but an acceleration of neuronal, differentiation of embryonic stem cells in vitro. Dev Biol. . 1998; 201: 167–184.[Medline] [Order article via Infotrieve]
121.
Baudoin C, Goumans MJ, Mummery C, Sonnenberg A. Knockout and knockin of the ß1 exon D define distinct roles for integrin splice variants in heart function and embryonic development. Genes Dev. . 1998; 12: 1202–1216.
122.
Borg TK, Goldsmith EC, Price R, Carver W, Terracio L, Samarel AM. Specialization at the Z line of cardiac myocytes. Cardiovasc Res. . 2000; 46: 277–285.
123.
Keller RS, Shai SY, Babbitt CJ, Pham CG, Solaro RJ, Valencik ML, Loftus JC, Ross RS. Disruption of integrin function in the murine myocardium leads to perinatal lethality, fibrosis, and abnormal cardiac performance. Am J Pathol. . 2001; 158: 1079–1090.
124.
Valencik ML, McDonald JA. Cardiac expression of a gain-of-function 5-integrin results in perinatal lethality. Am J Physiol Heart Circ Physiol. . 2001; 280: H361–H367.
125. McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL. Mice lacking ß3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest. . 2000; 105: 433–440.[Medline] [Order article via Infotrieve]
126.
De Arcangelis A, Mark M, Kreidberg J, Sorokin L, Georges-Labouesse E. Synergistic activities of 3 and 6 integrins are required during apical ectodermal ridge formation and organogenesis in the mouse. Development. . 1999; 126: 3957–3968.[Abstract]
127.
Miner JH, Cunningham J, Sanes JR. Roles for laminin in embryogenesis: exencephaly, syndactyly, and placentopathy in mice lacking the laminin 5 chain. J Cell Biol. . 1998; 143: 1713–1723.
128. Zimmerman D, Jin F, Leboy P, Hardy S, Damsky C. Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts. Dev Biol. . 2000; 220: 2–15.[Medline] [Order article via Infotrieve]
129.
Menko AS, Kreidberg JA, Ryan TT, Van Bockstaele E, Kukuruzinska MA. Loss of 3ß1 integrin function results in an altered differentiation program in the mouse submandibular gland. Dev Dyn. . 2001; 220: 337–349.[Medline]
[Order article via Infotrieve]
130.
Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF. Integrin 8ß1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell. . 1997; 88: 603–613.[Medline]
[Order article via Infotrieve]
131.
Denda S, Reichardt LF, Muller U. Identification of osteopontin as a novel ligand for the integrin 8ß1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell. . 1998; 9: 1425–1435.
132. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res. . 1998; 13: 1101–1111.[Medline] [Order article via Infotrieve]
133.
Littlewood Evans A, Muller U. Stereocilia defects in the sensory hair cells of the inner ear in mice deficient in integrin 8ß1. Nat Genet. 2000;24:424–428.
134. Grotewiel MS, Beck CD, Wu KH, Zhu XR, Davis RL. Integrin-mediated short-term memory in Drosophila. Nature. . 1998; 391: 455–460.[Medline] [Order article via Infotrieve]
135.
Anton ES, Kreidberg JA, Rakic P. Distinct functions of 3 and v integrin receptors in neuronal migration and laminar organization of the cerebral cortex. Neuron. . 1999; 22: 277–289.[Medline]
[Order article via Infotrieve]
136.
Dulabon L, Olson EC, Taglienti MG, Eisenhuth S, McGrath B, Walsh CA, Kreidberg JA, Anton ES. Reelin binds 3ß1 integrin and inhibits neuronal migration. Neuron. . 2000; 27: 33–44.[Medline]
[Order article via Infotrieve]
137.
Georges-Labouesse E, Mark M, Messaddeq N, Gansmuller A. Essential role of 6 integrins in cortical and retinal lamination. Curr Biol. . 1998; 8: 983–986.[Medline]
[Order article via Infotrieve]
138.
Miner JH, Li C. Defective glomerulogenesis in the absence of laminin 5 demonstrates a developmental role for the kidney glomerular basement membrane. Dev Biol. . 2000; 217: 278–289.[Medline]
[Order article via Infotrieve]
139.
Werner A, Willem M, Jones LL, Kreutzberg GW, Mayer U, Raivich G. Impaired axonal regeneration in 7 integrin-deficient mice. J Neurosci. . 2000; 20: 1822–1830.
140. Aplin AE, Howe AK, Juliano RL. Cell adhesion molecules, signal transduction and cell growth. Curr Opin Cell Biol. . 1999; 11: 737–744.[Medline] [Order article via Infotrieve]
141.
Saher G, Hildt E. Activation of c-Raf-1 kinase signal transduction pathway in 7 integrin-deficient mice. J Biol Chem. . 1999; 274: 27651–27657.
142.
Giancotti FG, Ruoslahti E. Integrin signaling. Science. . 1999; 285: 1028–1032.
143.
Pozzi A, Wary KK, Giancotti FG, Gardner HA. Integrin 1ß1 mediates a unique collagen-dependent proliferation pathway in vivo. J Cell Biol. . 1998; 142: 587–594.
144. Faraldo MM, Deugnier MA, Lukashev M, Thiery JP, Glukhova MA. Perturbation of ß1-integrin function alters the development of murine mammary gland. EMBO J. . 1998; 17: 2139–2147.[Medline] [Order article via Infotrieve]
145. Faraldo MM, Deugnier MA, Lukashev M, Thiery JP, Glukhova MA. Growth defects induced by perturbation of ß1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways. EMBO Rep. . 2001; 2: 431–437.[Medline] [Order article via Infotrieve]
146. Murgia C, Blaikie P, Kim N, Dans M, Petrie HT, Giancotti FG. Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin ß4 cytoplasmic domain. EMBO J. . 1998; 17: 3940–3951.[Medline] [Order article via Infotrieve]
147. Gardner HA. Integrin signaling in fibrosis and scleroderma. Curr Rheumatol Rep. . 1999; 1: 28–33.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  B. Bystrom, S. Carracedo, A. Behndig, D. Gullberg, and F. Pedrosa-Domellof {alpha}11 Integrin in the Human Cornea: Importance in Development and Disease Invest. Ophthalmol. Vis. Sci., November 1, 2009; 50(11): 5044 - 5053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Schreiber, C. Steinl, M. Essl, H. Abele, K. Geiger, C. A. Muller, W. K. Aicher, and G. Klein The integrin {alpha}9{beta}1 on hematopoietic stem and progenitor cells: involvement in cell adhesion, proliferation and differentiation Haematologica, November 1, 2009; 94(11): 1493 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Nishimura Integrin-Mediated Transforming Growth Factor-{beta} Activation, a Potential Therapeutic Target in Fibrogenic Disorders Am. J. Pathol., October 1, 2009; 175(4): 1362 - 1370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Okazaki, A. Ni, O. A. Ayeni, P. Baluk, L.-C. Yao, D. Vossmeyer, G. Zischinsky, G. Zahn, J. Knolle, C. Christner, et al. {alpha}5{beta}1 Integrin Blockade Inhibits Lymphangiogenesis in Airway Inflammation Am. J. Pathol., June 1, 2009; 174(6): 2378 - 2387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Legate, S. A. Wickstrom, and R. Fassler Genetic and cell biological analysis of integrin outside-in signaling Genes & Dev., February 15, 2009; 23(4): 397 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sayers, L. J. Sundberg-Smith, M. Rojas, H. Hayasaka, J. T. Parsons, C. P. Mack, and J. M. Taylor FRNK Expression Promotes Smooth Muscle Cell Maturation During Vascular Development and After Vascular Injury Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2115 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kinsey, M. R. Williamson, S. Chaudhry, K. T. Mellody, A. McGovern, S. Takahashi, C. A. Shuttleworth, and C. M. Kielty Fibrillin-1 microfibril deposition is dependent on fibronectin assembly J. Cell Sci., August 15, 2008; 121(16): 2696 - 2704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Sundberg-Smith, L. A. DiMichele, R. L. Sayers, C. P. Mack, and J. M. Taylor The LIM Protein Leupaxin Is Enriched in Smooth Muscle and Functions As an Serum Response Factor Cofactor to Induce Smooth Muscle Cell Gene Transcription Circ. Res., June 20, 2008; 102(12): 1502 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. McCarty, M. Barry, D. Crowley, R. T. Bronson, A. Lacy-Hulbert, and R. O. Hynes Genetic Ablation of {alpha}v Integrins in Epithelial Cells of the Eyelid Skin and Conjunctiva Leads to Squamous Cell Carcinoma Am. J. Pathol., June 1, 2008; 172(6): 1740 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Abraham, N. Kogata, R. Fassler, and R. H. Adams Integrin {beta}1 Subunit Controls Mural Cell Adhesion, Spreading, and Blood Vessel Wall Stability Circ. Res., March 14, 2008; 102(5): 562 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-V. Wang, L.-W. Chang, K. Brixius, S. A. Wickstrom, E. Montanez, I. Thievessen, M. Schwander, U. Muller, W. Bloch, U. Mayer, et al. Integrin-linked kinase stabilizes myotendinous junctions and protects muscle from stress-induced damage J. Cell Biol., March 5, 2008; 180(5): 1037 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Karsan Notch and Integrin Affinity: A Sticky Situation Sci. Signal., January 15, 2008; 1(2): pe2 - pe2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Takahashi, M. Leiss, M. Moser, T. Ohashi, T. Kitao, D. Heckmann, A. Pfeifer, H. Kessler, J. Takagi, H. P. Erickson, et al. The RGD motif in fibronectin is essential for development but dispensable for fibril assembly J. Cell Biol., October 3, 2007; 178(1): 167 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Meighan and J. E. Schwarzbauer Control of C. elegans hermaphrodite gonad size and shape by vab-3/Pax6-mediated regulation of integrin receptors Genes & Dev., July 1, 2007; 21(13): 1615 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Humphries, A. Byron, and M. J. Humphries Integrin ligands at a glance. J. Cell Sci., October 1, 2006; 119(Pt 19): 3901 - 3903. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stefanidakis and E. Koivunen Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression Blood, September 1, 2006; 108(5): 1441 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wang, J. Li, K. Lyte, N. K. Yashpal, F. Fellows, and C. G. Goodyer Role for {beta}1 Integrin and Its Associated {alpha}3, {alpha}5, and {alpha}6 Subunits in Development of the Human Fetal Pancreas Diabetes, July 1, 2005; 54(7): 2080 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Semmrich, A. Smith, C. Feterowski, S. Beer, B. Engelhardt, D. H. Busch, B. Bartsch, M. Laschinger, N. Hogg, K. Pfeffer, et al. Importance of integrin LFA-1 deactivation for the generation of immune responses J. Exp. Med., June 20, 2005; 201(12): 1987 - 1998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Raymond, M. Kreft, H. Janssen, J. Calafat, and A. Sonnenberg Keratinocytes display normal proliferation, survival and differentiation in conditional {beta}4-integrin knockout mice J. Cell Sci., March 1, 2005; 118(5): 1045 - 1060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bengtsson, A. Aszodi, C. Nicolae, E. B. Hunziker, E. Lundgren-Akerlund, and R. Fassler Loss of {alpha}10{beta}1 integrin expression leads to moderate dysfunction of growth plate chondrocytes J. Cell Sci., March 1, 2005; 118(5): 929 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Peng, H. Ueda, H. Zhou, T. Stokol, T.-L. Shen, A. Alcaraz, T. Nagy, J.-D. Vassalli, and J.-L. Guan Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice Cardiovasc Res, December 1, 2004; 64(3): 421 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Garciadiego-Cazares, C. Rosales, M. Katoh, and J. Chimal-Monroy Coordination of chondrocyte differentiation and joint formation by {alpha}5{beta}1 integrin in the developing appendicular skeleton Development, October 1, 2004; 131(19): 4735 - 4742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pietri, O. Eder, M. A. Breau, P. Topilko, M. Blanche, C. Brakebusch, R. Fassler, J.-P. Thiery, and S. Dufour Conditional {beta}1-integrin gene deletion in neural crest cells causes severe developmental alterations of the peripheral nervous system Development, August 15, 2004; 131(16): 3871 - 3883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Goel, M. Fornaro, L. Moro, N. Teider, J. S. Rhim, M. King, and L. R. Languino Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by {beta}1 integrins J. Cell Biol., August 2, 2004; 166(3): 407 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K.Y. Siu and C. Y. Cheng Extracellular Matrix: Recent Advances on Its Role in Junction Dynamics in the Seminiferous Epithelium During Spermatogenesis Biol Reprod, August 1, 2004; 71(2): 375 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stefanidakis, T. Ruohtula, N. Borregaard, C. G. Gahmberg, and E. Koivunen Intracellular and Cell Surface Localization of a Complex between {alpha}M{beta}2 Integrin and Promatrix Metalloproteinase-9 Progelatinase in Neutrophils J. Immunol., June 1, 2004; 172(11): 7060 - 7068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Aszodi, E. B. Hunziker, C. Brakebusch, and R. Fassler {beta}1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis Genes & Dev., October 1, 2003; 17(19): 2465 - 2479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Haas, K. Amann, J. Schittny, B. Blaser, U. Muller, and A. Hartner Glomerular and Renal Vascular Structural Changes in {alpha}8 Integrin-Deficient Mice J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2288 - 2296. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Sundberg, L. M. Galante, H. M. Bill, C. P. Mack, and J. M. Taylor An Endogenous Inhibitor of Focal Adhesion Kinase Blocks Rac1/JNK but Not Ras/ERK-dependent Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., August 8, 2003; 278(32): 29783 - 29791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-S. Chan, E. J. Weeber, S. Kurup, J. D. Sweatt, and R. L. Davis Integrin Requirement for Hippocampal Synaptic Plasticity and Spatial Memory J. Neurosci., August 6, 2003; 23(18): 7107 - 7116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Mostafavi-Pour, J. A. Askari, S. J. Parkinson, P. J. Parker, T. T.C. Ng, and M. J. Humphries Integrin-specific signaling pathways controlling focal adhesion formation and cell migration J. Cell Biol., April 14, 2003; 161(1): 155 - 167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-M. Zhang, J. Kapyla, J. S. Puranen, C. G. Knight, C.-F. Tiger, O. T. Pentikainen, M. S. Johnson, R. W. Farndale, J. Heino, and D. Gullberg alpha 11beta 1 Integrin Recognizes the GFOGER Sequence in Interstitial Collagens J. Biol. Chem., February 21, 2003; 278(9): 7270 - 7277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Sussman, A. McCulloch, and T. K. Borg Dance Band on the Titanic: Biomechanical Signaling in Cardiac Hypertrophy Circ. Res., November 15, 2002; 91(10): 888 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R L Wilder Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases Ann Rheum Dis, November 1, 2002; 61(90002): ii96 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Ustinov and E. F. Plow Delineation of the Key Amino Acids Involved in Neutrophil Inhibitory Factor Binding to the I-domain Supports a Mosaic Model for the Capacity of Integrin alpha Mbeta 2 to Recognize Multiple Ligands J. Biol. Chem., May 17, 2002; 277(21): 18769 - 18776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Eliceiri Integrin and Growth Factor Receptor Crosstalk Circ. Res., December 7, 2001; 89(12): 1104 - 1110. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||